XML 22 R11.htm IDEA: XBRL DOCUMENT v3.25.0.1
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS
3 Months Ended
Sep. 30, 2024
Restatement Of Previously Issued Financial Statements  
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

NOTE 2 — RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS

 

During the preparation of the Company’s Form 10-Q for the period ended December 31, 2024, the Company determined that certain warrants which were exercised during the three months ended March 31, 2024, had not been appropriately reflected as a component of the change in fair value of the contingent consideration for the year ended June 30, 2024. The number of shares underlying these warrants was 3,425,399 which had a fair value of $7,775,656 on the date of exercise.

 

The impact of the restatement on these financial statements by line item is as follows: 

         
   As Reported  Change  As Restated
Common stock  $15,763   $343   $16,106 
Additional paid-in capital  $460,665,481   $7,775,313   $468,440,794 
Accumulated deficit  $(368,891,461)  $(7,775,656)  $(376,667,117)